Vascular risk factors and the effect of white matter lesions on extrapyramidal signs in Alzheimer's disease

ABSTRACT Background: Extrapyramidal signs (EPSs), which are important characteristics of Parkinson's disease (PD), occur frequently in Alzheimer's disease (AD). Although AD and PD share common clinical features such as EPSs, these diseases vary with respect to vascular risk factors. The presence of vascular risk factors increases the risk of AD; however, these factors have been known to be inversely associated with PD. We aimed to assess the effect of vascular risk factors and white matter lesions (WMLs) on EPSs in AD. Methods: We recruited 1,187 AD patients and 333 controls with neither cognitive impairment nor EPSs. All participants underwent detailed clinical evaluations which included assessments of vascular risk factors, cognitive function, and EPSs, as well as WMLs on brain MRIs. EPS subtypes were classified into tremor-dominant, postural instability gait difficulty, or indeterminate; WMLs subtypes were classified into periventricular WML (pvWML) or deep WML (dWML). Results: EPSs were present in 17.9% of subjects with AD and were significantly associated with vascular risk factors such as age, male gender, diabetes mellitus, and WMLs. Additionally, a multivariate logistic regression analysis showed that EPSs in AD were associated with pvWML (odds ratio (OR), 1.61–2.52), not with dWML. With respect to EPS subtypes, the majority (78.4%) of EPSs in AD were postural instability gait difficulty, which was also associated with WMLs (OR 1.84–2.41), pvWML (OR 2.09–3.14), and dWML (OR 1.83–3.42). Conclusions: EPSs in AD are associated with selected vascular risk factors as well as WMLs.

[1]  R. Mayeux,et al.  Heterogeneity in dementia of the Alzheimer type , 1985, Neurology.

[2]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[3]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[4]  T. Robbins,et al.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.

[5]  J. Morris,et al.  The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs , 2005, Neurology.

[6]  P. Piccini,et al.  White matter hyperintensities in Parkinson's disease. Clinical correlations. , 1995, Archives of neurology.

[7]  M. Hennerici,et al.  Are gait disturbances and white matter degeneration early indicators of vascular dementia? , 1994, Dementia.

[8]  M. Merello,et al.  Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[9]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[10]  Lawrence S. Honig,et al.  Atherosclerosis and AD : Analysis of data from the US national Alzheimer's coordinating center. Author's reply , 2005 .

[11]  J. MacFall,et al.  Classification of White Matter Lesions on Magnetic Resonance Imaging in Elderly Persons , 2008, Biological Psychiatry.

[12]  Yaakov Stern,et al.  The absence of an apolipoprotein ϵ4 allele is associated with a more aggressive form of Alzheimer's disease , 1997, Annals of neurology.

[13]  B. Bloem,et al.  Neurological gait disorders in elderly people: clinical approach and classification , 2007, The Lancet Neurology.

[14]  T. Beach,et al.  Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center , 2005, Neurology.

[15]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[16]  J. Brandt,et al.  Motor signs during the course of Alzheimer disease , 2004, Neurology.

[17]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[18]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[19]  R. Watts,et al.  The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism. , 1992, Neurologic clinics.

[20]  Kun-Woo Park,et al.  Cerebral Microbleeds Are Independently Associated with Arterial Stiffness in Stroke Patients , 2008, Cerebrovascular Diseases.

[21]  Alan Thomas,et al.  Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross‐sectional comparative study , 2003, Movement disorders : official journal of the Movement Disorder Society.

[22]  F. Vaglini,et al.  Nicotine Prevents Experimental Parkinsonism in Rodents and Induces Striatal Increase of Neurotrophic Factors , 1998, Journal of neurochemistry.

[23]  C. Fowler,et al.  Dopamine and glutamate neurotoxicity in cultured chick telencephali cells: effects of nmda antagonists, antioxidants and mao inhibitors , 1999, Neurochemistry International.

[24]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[25]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[26]  R. Baloh,et al.  A longitudinal study of gait and balance dysfunction in normal older people. , 2003, Archives of neurology.

[27]  J. C. de la Torre,et al.  For Personal Use. Only Reproduce with Permission the Lancet Publishing Group. Personal View Is Ad Neurodegenerative or Vascular? Is Ad Neurodegenerative? Is Alzheimer's Disease a Neurodegenerative or a Vascular Disorder? Data, Dogma, and Dialectics , 2022 .

[28]  I. Jo,et al.  Carotid intima‐media thickness in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[29]  T. Brannelly.  Negotiating ethics in dementia care , 2006 .

[30]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[31]  Herman Buschke,et al.  Abnormality of gait as a predictor of non-Alzheimer's dementia. , 2002, The New England journal of medicine.

[32]  Y. Stern,et al.  Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study. , 2009, Archives of neurology.